S.AMDT 178 TO S.CON RES. 3
To Allow for the Importation of Prescription Drugs in the FY 17 Budget Resolution
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Introduced on January 3, 2017
Roll Number 20
on January 12, 2017
(This measure has not been amended since it was passed by the Senate on January 12, 2017. The summary of that version is repeated here.) Highlights: This concurrent resolution establishes the FY2017 congressional budget resolution, which provides a framework for congressional consideration of revenue, spending, and other budget-related legislation. The budget resolution is a nonbinding framework used by Congress and cannot be signed into law or vetoed by the President. The resolution establishes budget enforcement procedures by setting forth rules for applying budget points of order to various legislative proposals. It also includes reconciliation instructions directing various congressional committees to submit to the congressional budget committees deficit reduction legislation, which Congress must then consider using expedited legislative procedures. The resolution includes reserve funds that provide the chairmen of the congressional budget committees with flexibility in applying budget enforcement rules to health care legislation that meets specified criteria. Full Summary: Establishes the congressional budget for the federal government for FY2017 and sets forth budgetary levels for FY2018-FY2026. TITLE I--RECOMMENDED LEVELS AND AMOUNTS Subtitle A--Budgetary Levels in Both Houses (Sec. 1101) Recommends levels and amounts for FY2017-FY2026 for: federal revenues, new budget authority, budget outlays, deficits, public debt, and debt held by the public. (Sec. 1102) Recommends levels of new budget authority and outlays for FY2017-FY2026 for each major functional category, including: National Defense; International Affairs; General Science, Space, and Technology; Energy; Natural Resources and Environment; Agriculture; Commerce and Housing Credit; Transportation; Community and Regional Development; Education, Training, Employment, and Social Services; Health; Medicare; Income Security; Social Security; Veterans Benefits and Services; Administration of Justice; General Government; Net Interest; Allowances; and Undistributed Offsetting Receipts. Subtitle B--Levels and Amounts in the Senate (Sec. 1201) Recommends Senate levels for FY2017-FY2026 for Social Security revenues, outlays, and administrative expenses. (Sec. 1202) Recommends Senate levels of new budget authority and outlays for FY2017-FY2026 for U.S. Postal Service discretionary administrative expenses. TITLE II--RECONCILIATION (Title II includes reconciliation instructions directing congressional committees to submit deficit reduction legislation to the budget committees. Under the Congressional Budget Act of 1974, reconciliation bills are considered by Congress using expedited legislative procedures that prevent a filibuster and restrict amendments in the Senate.) (Sec. 2001) Includes reconciliation instructions directing the Senate Finance Committee and the Senate Health, Education, Labor, and Pensions Committee to each submit to the Senate Budget Committee legislation to reduce the deficit by at least $1 billion over the FY2017-FY2026 period. Requires the legislation to be submitted by January 27, 2017. (Sec. 2002) Includes reconciliation instructions directing the House Energy and Commerce Committee and the House Ways and Means Committee to each submit to the House Budget Committee legislation to reduce the deficit by at least $1 billion over the FY2017-FY2026 period. Requires the legislation to be submitted by January 27, 2017. TITLE III--RESERVE FUNDS Establishes reserve funds that provide the chairmen of the congressional budget committees with flexibility in applying budget enforcement rules to health care legislation that meets specified criteria. (Under the reserve funds, the chairmen may revise committee allocations, aggregates and other appropriate levels in this resolution, and the pay-as-you-go [PAYGO] ledger in the Senate.) (Sec. 3001) Establishes a deficit-neutral reserve fund for health care legislation that would not increase the deficit over the FY2017-FY2016 period. (Sec. 3002) Establishes a reserve fund for health care legislation. Specifies that the adjustments permitted under this section may not exceed the difference obtained from subtracting $2 billion from the sum of deficit reduction over the period of the total of fiscal years FY2017-FY2026 achieved under legislation for which the chairman has exercised authority under the deficit-neutral reserve fund in section 3001. Specifies that, in the House and the Senate, legislation for which the chairman of the applicable budget committee has exercised authority pursuant to this section is exempt from: (1) the point of order against legislation increasing the short-term deficit, and (2) the point of order against legislation increasing long-term deficits or direct spending. (The short-term deficit point of order prohibits the Senate from considering legislation that would cause a net increase in the deficit in excess of $10 billion in any fiscal year provided for in the most recently adopted budget resolution unless it is fully offset over the period of all fiscal years provided for in the most recently adopted budget resolution. The long-term point of order applies to legislation that would cause a net-increase in on budget-deficits in the Senate or a net increase in direct spending in the House in excess of $5 billion in any of the 4 consecutive 10-year periods beginning with the first fiscal year that is 10 years after the budget year provided for in the most recently adopted budget resolution.) TITLE IV-OTHER MATTERS (Sec. 4001) Provides that, for the purposes of enforcing the Congressional Budget Act of 1974, the chairmen of the congressional budget committees may submit for publication in the Congressional Record allocations that are normally included in the joint statement of managers accompanying a conference report. (Sec. 4002) Provides that the discretionary administrative expenses of the Social Security Administration and the U.S. Postal Service are reflected in the allocation to the appropriations committees to ensure that the committees retain control over the expenses through the annual appropriations process. Requires the administrative expenses to be included in the cost estimates for appropriations legislation for budget enforcement purposes. (Sec. 4003) Sets forth procedures for adjustments of the allocations and aggregates included in the budget resolution. Specifies that legislation for which the House Budget Committee Chairman has made adjustments or revisions in the allocations, aggregates, and other budgetary levels of this concurrent resolution is exempt from: (1) the Cut-As-You-Go point of order, and (2) the point of order against legislation increasing long-term direct spending. (The Cut-As-You-Go point of order prohibits the House from considering legislation that would have the net effect of increasing direct spending over specified time periods. The long-term point of order prohibits the House from considering legislation that would cause a net increase in direct spending in excess of $5 billion in any of the 4 consecutive 10-year periods beginning with the first fiscal year that is 10 years after the budget year provided for in the most recently adopted budget resolution. This provision effectively allows the House Budget Committee Chairman to exempt from the points of order health care legislation that qualifies for the reserve funds in title III.) (Sec. 4004) Affirms that this budget resolution is adopted as an exercise of the rulemaking powers of the House and Senate and that either chamber has the constitutional right to change these rules.
Vote on Amendment 178 to S. Con. Res. 3, offered by Senators Amy Klobuchar (D-MN) and Bernie Sanders (I-VT). Amendment 178 would permit the importation of prescription drugs, biologics and devices outside the current safety system established by the FDA by allowing for pharmaceutical importation from Canada. Importation and re-importation could expose consumers to counterfeit and adulterated therapies.